4//SEC Filing
Freeman Kevin Lee 4
Accession 0001562180-24-006686
CIK 0001636422other
Filed
Sep 4, 8:00 PM ET
Accepted
Sep 5, 4:42 PM ET
Size
7.1 KB
Accession
0001562180-24-006686
Insider Transaction Report
Form 4
Freeman Kevin Lee
Chief Commercial Officer
Transactions
- Tax Payment
Common Stock
2024-09-03$7.27/sh−2,772$20,150→ 263,381 total - Sale
Common Stock
2024-09-03$7.22/sh−7,500$54,174→ 255,881 total
Footnotes (2)
- [F1]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
- [F2]The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 12, 2024 in accordance with Rule 10b5-1.
Documents
Issuer
Health Catalyst, Inc.
CIK 0001636422
Entity typeother
Related Parties
1- filerCIK 0001945797
Filing Metadata
- Form type
- 4
- Filed
- Sep 4, 8:00 PM ET
- Accepted
- Sep 5, 4:42 PM ET
- Size
- 7.1 KB